BRIDGEBIO PHARMA INC (BBIO)
US10806X1028 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to BBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 49.98. This target is 100.32% above the current price.
BBIO was analyzed by 20 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about BBIO.
In the previous month the buy percentage consensus was at a similar level.
BBIO was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-19 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-03-11 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-03-05 | Mizuho | Maintains | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-23 | Citigroup | Maintains | Buy -> Buy |
| 2024-01-31 | BMO Capital | Initiate | Market Perform |
| 2024-01-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-07 | Citigroup | Initiate | Buy |
| 2023-10-24 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-08-28 | Mizuho | Reiterate | Buy -> Buy |
| 2023-08-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-14 | Mizuho | Maintains | Buy -> Buy |
| 2023-07-18 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-07-18 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-07-18 | Jefferies | Downgrade | Buy -> Hold |
| 2023-05-08 | Mizuho | Maintains | Buy |
| 2023-04-19 | Evercore ISI Group | Initiate | Outperform |
| 2023-04-13 | SVB Securities | Maintains | Outperform |
| 2023-03-07 | Raymond James | Maintains | Outperform |
| 2023-03-07 | JP Morgan | Maintains | Overweight |
| 2023-03-07 | Goldman Sachs | Maintains | Buy |
| 2023-02-06 | Cowen & Co. | Initiate | Outperform |
| 2023-01-23 | SVB Leerink | Maintains | Outperform |
| 2022-11-18 | JP Morgan | Maintains | Overweight |
| 2022-08-24 | Mizuho | Maintains | Buy |
| 2022-07-26 | SVB Leerink | Maintains | Outperform |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-05-06 | SVB Leerink | Maintains | Outperform |